Endothelial Progenitor Cells in Breast Cancer

Monica C Botelho*, Helena Alves

Recent evidences demonstrated the importance of bone marrow derived Endothelial  rogenitor Cells (EPC), in the contribution to postnatal physiological and pathological neovascularization, and in tumor growth and angiogenesis. These cells are recruited undifferentiated, in response to systemic or chemoactractive signals, such as Vascular Endothelial Growth Factor (VEGF), they lodge in the growing or lesioned tissue and  ifferentiate into endothelial cells in response to local stimuli and cell-cell interactions.The extent and the significance of the EPCs contribution for the growing of most tumors, including those of the breast, are still not fully defined. We analyzed the peripheral blood of breast cancer patients and found that they have circulating EPCs. We also found an  association between expression of AC133+Kdr+ and VEGF plasma levels in these patients. Strategies to impair the mobilization and incorporation of EPCs into breast tumors may contribute to halt the growth of these tumors.

Pubmed link: https://www.ncbi.nlm.nih.gov/pubmed/26878074

Keywords: Breast cancer; Endothelial progenitor cells; AC133; KDR, VEGF

Published on: Jan 23, 2016 Pages: 1-2

Full Text PDF Full Text HTML DOI: 10.17352/2455-8591.000007
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat